AstraZeneca is a company with a turbulent history but, for now ... perhaps underlining the importance of AZ to the country’s life sciences sector, with both AZ and Pfizer asked to argue for ...

Two years ago, the Pharmaceutical Research and Manufacturers of America (PhRMA) trade group faced a mini-exodus as several ...

The country has a large number of small biotech companies, and one or two speciality pharma firms, but nothing on the scale of AstraZeneca. AstraZeneca - a lost cause? Sweden's enterprise minister ...

By Maggie Fick LONDON (Reuters) -AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe ...

AstraZeneca is scheduled to report results for the first quarter on Tuesday. Here is what you need to know.

CHINA DAILY Multinational pharmaceutical company AstraZeneca is bullish about China's role as a global innovation powerhouse, underpinned by the country's sound prospects as well as its growing ...

AstraZeneca relies more on China than most of its peers. The company generated nearly 12% of its revenue last year in the country, an exposure that came under investors’ scrutiny after Chinese ...

AstraZeneca CEO Pascal Soriot said in a statement. With the latest investments in Beijing, the drug maker will have two global R&D centres in the country – the other in Shanghai – to advance ...

LONDON, April 23 (Reuters) - AstraZeneca Chief Executive Officer ... Donald Trump's efforts to bring more investment to his country are reducing incentives to invest in Europe.